Literature DB >> 25530917

Shiga Toxin (Stx) Classification, Structure, and Function.

Angela R Melton-Celsa1.   

Abstract

Shiga toxin (Stx) is one of the most potent bacterial toxins known. Stx is found in Shigella dysenteriae 1 and in some serogroups of Escherichia coli (called Stx1 in E. coli). In addition to or instead of Stx1, some E. coli strains produce a second type of Stx, Stx2, that has the same mode of action as Stx/Stx1 but is antigenically distinct. Because subtypes of each toxin have been identified, the prototype toxin for each group is now designated Stx1a or Stx2a. The Stxs consist of two major subunits, an A subunit that joins noncovalently to a pentamer of five identical B subunits. The A subunit of the toxin injures the eukaryotic ribosome and halts protein synthesis in target cells. The function of the B pentamer is to bind to the cellular receptor, globotriaosylceramide, Gb3, found primarily on endothelial cells. The Stxs traffic in a retrograde manner within the cell, such that the A subunit of the toxin reaches the cytosol only after the toxin moves from the endosome to the Golgi and then to the endoplasmic reticulum. In humans infected with Stx-producing E. coli, the most serious manifestation of the disease, hemolytic-uremic syndrome, is more often associated with strains that produce Stx2a rather than Stx1a, and that relative toxicity is replicated in mice and baboons. Stx1a and Stx2a also exhibit differences in cytotoxicity to various cell types, bind dissimilarly to receptor analogs or mimics, induce differential chemokine responses, and have several distinctive structural characteristics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25530917      PMCID: PMC4270005          DOI: 10.1128/microbiolspec.EHEC-0024-2013

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  140 in total

1.  Elastase in intestinal mucus enhances the cytotoxicity of Shiga toxin type 2d.

Authors:  J F Kokai-Kun; A R Melton-Celsa; A D O'Brien
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

Review 2.  Edema disease.

Authors:  R A Moxley
Journal:  Vet Clin North Am Food Anim Pract       Date:  2000-03       Impact factor: 3.357

3.  Association of virulence genotype with phylogenetic background in comparison to different seropathotypes of Shiga toxin-producing Escherichia coli isolates.

Authors:  Jean Pierre Girardeau; Alessandra Dalmasso; Yolande Bertin; Christian Ducrot; Séverine Bord; Valérie Livrelli; Christine Vernozy-Rozand; Christine Martin
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

4.  Shiga toxin induces tubular membrane invaginations for its uptake into cells.

Authors:  Winfried Römer; Ludwig Berland; Valérie Chambon; Katharina Gaus; Barbara Windschiegl; Danièle Tenza; Mohamed R E Aly; Vincent Fraisier; Jean-Claude Florent; David Perrais; Christophe Lamaze; Graça Raposo; Claudia Steinem; Pierre Sens; Patricia Bassereau; Ludger Johannes
Journal:  Nature       Date:  2007-11-29       Impact factor: 49.962

5.  Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3.

Authors:  H Ling; A Boodhoo; B Hazes; M D Cummings; G D Armstrong; J L Brunton; R J Read
Journal:  Biochemistry       Date:  1998-02-17       Impact factor: 3.162

6.  Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome.

Authors:  Martina Bielaszewska; Alexander W Friedrich; Thomas Aldick; Robin Schürk-Bulgrin; Helge Karch
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

7.  Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration.

Authors:  B P Hurley; C M Thorpe; D W Acheson
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

8.  Cytotoxicity of Shigella dysenteriae 1 for cultured mammalian cells.

Authors:  T L Hale; S B Formal
Journal:  Am J Clin Nutr       Date:  1980-11       Impact factor: 7.045

9.  Dietary choice affects Shiga toxin-producing Escherichia coli (STEC) O157:H7 colonization and disease.

Authors:  Steven D Zumbrun; Angela R Melton-Celsa; Mark A Smith; Jeremy J Gilbreath; D Scott Merrell; Alison D O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

10.  Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells.

Authors:  M S Jacewicz; D W Acheson; M Mobassaleh; A Donohue-Rolfe; K A Balasubramanian; G T Keusch
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

View more
  128 in total

1.  Influence of RNase E deficiency on the production of stx2-bearing phages and Shiga toxin in an RNase E-inducible strain of enterohaemorrhagic Escherichia coli (EHEC) O157:H7.

Authors:  Thujitha Thuraisamy; Patricia B Lodato
Journal:  J Med Microbiol       Date:  2018-04-05       Impact factor: 2.472

2.  Virulence Factor Cargo and Host Cell Interactions of Shiga Toxin-Producing Escherichia coli Outer Membrane Vesicles.

Authors:  Martina Bielaszewska; Lilo Greune; Andreas Bauwens; Petra Dersch; Alexander Mellmann; Christian Rüter
Journal:  Methods Mol Biol       Date:  2021

3.  Identification of Antibiotics That Diminish Disease in a Murine Model of Enterohemorrhagic Escherichia coli Infection.

Authors:  Sabrina Mühlen; Isabell Ramming; Marina C Pils; Martin Koeppel; Jana Glaser; John Leong; Antje Flieger; Bärbel Stecher; Petra Dersch
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

4.  Metabolomic analysis of Shiga toxin 2a-induced injury in conditionally immortalized glomerular endothelial cells.

Authors:  Christian Patry; Kathrin Plotnicki; Christian Betzen; Alba Perez Ortiz; Kirk L Pappan; Simon C Satchell; Peter W Mathieson; Martina Bielaszewska; Helge Karch; Burkhard Tönshoff; Neysan Rafat
Journal:  Metabolomics       Date:  2019-10-01       Impact factor: 4.290

5.  Development and Evaluation of a Novel VHH-Based Immunocapture Assay for High-Sensitivity Detection of Shiga Toxin Type 2 (Stx2) in Stool Samples.

Authors:  Luciano J Melli; Vanesa Zylberman; Yanina Hiriart; Constanza E Lauche; Ariela Baschkier; Romina Pardo; Elizabeth Miliwebsky; Isabel Chinen; Marta Rivas; Fernando A Goldbaum; Juan E Ugalde; Diego J Comerci; Andrés E Ciocchini
Journal:  J Clin Microbiol       Date:  2020-02-24       Impact factor: 5.948

6.  Nano-multilamellar lipid vesicles (NMVs) enhance protective antibody responses against Shiga toxin (Stx2a) produced by enterohemorrhagic Escherichia coli strains (EHEC).

Authors:  M J Rodrigues-Jesus; W L Fotoran; R M Cardoso; K Araki; G Wunderlich; Luís C S Ferreira
Journal:  Braz J Microbiol       Date:  2018-12-06       Impact factor: 2.476

7.  Prevalence and Genomic Characterization of Escherichia coli O157:H7 in Cow-Calf Herds throughout California.

Authors:  Jay N Worley; Kristopher A Flores; Xun Yang; Jennifer A Chase; Guojie Cao; Shuai Tang; Jianghong Meng; Edward R Atwill
Journal:  Appl Environ Microbiol       Date:  2017-08-01       Impact factor: 4.792

8.  Distribution and characterization of Shiga toxin converting temperate phages carried by Shigella flexneri in Hispaniola.

Authors:  Marta Fogolari; Carla Mavian; Silvia Angeletti; Marco Salemi; Keith A Lampel; Anthony T Maurelli
Journal:  Infect Genet Evol       Date:  2018-07-31       Impact factor: 3.342

9.  Hybrid Shiga Toxin-Producing and Enterotoxigenic Escherichia sp. Cryptic Lineage 1 Strain 7v Harbors a Hybrid Plasmid.

Authors:  Susan R Leonard; Mark K Mammel; David A Rasko; David W Lacher
Journal:  Appl Environ Microbiol       Date:  2016-06-30       Impact factor: 4.792

10.  Vitamin K Analogs Influence the Growth and Virulence Potential of Enterohemorrhagic Escherichia coli.

Authors:  Anne Kijewski; Ingun Lund Witsø; Hildegunn Iversen; Helene Thorsen Rønning; Trine L'Abée-Lund; Yngvild Wasteson; Toril Lindbäck; Marina Aspholm
Journal:  Appl Environ Microbiol       Date:  2020-11-24       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.